Publicaciones en colaboración con investigadoras/es de Hospital Clínico Universitario Lozano Blesa (11)

2017

  1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

2015

  1. Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

    Gastroenterologia y Hepatologia, Vol. 38, Núm. 4, pp. 263-273

2011

  1. Celsior Versus University of Wisconsin Preserving Solutions for Liver Transplantation: Postreperfusion Syndrome and Outcome of a 5-Year Prospective Randomized Controlled Study

    World Journal of Surgery

2010

  1. Colorectal cancer prognosis twenty years later

    World Journal of Gastroenterology, Vol. 16, Núm. 7, pp. 862-867

  2. Outcome of liver transplantation using donors older than 60 year of age

    Clinical Transplantation, Vol. 24, Núm. 4, pp. 543-549

2009

  1. Trends in Barrett's esophagus diagnosis in Southern Europe: Implications for surveillance

    Diseases of the Esophagus, Vol. 22, Núm. 3, pp. 239-248

2007

  1. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

    American Journal of Gastroenterology, Vol. 102, Núm. 3, pp. 507-515

2006

  1. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate

    BMC Gastroenterology, Vol. 6

  2. Preservation of the Liver Graft With Celsior Solution

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2385-2388

2004

  1. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in Southern Europe

    Helicobacter, Vol. 9, Núm. 3, pp. 249-254

2003

  1. Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis

    Inflammation, Vol. 27, Núm. 1, pp. 21-29